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Quadricuspid aortic valve (QAV) is a rare congenital cardiac defect characterized by the presence of four aortic valve leaﬂets of
equal or varying sizes. Even rarer is its clinical presentation with aortic stenosis. Diagnosis of QAV could be challenging but is
of great importance as patients often present with progressive aortic regurgitation. We present 2 cases of QAV presenting
diﬀerently: one with aortic stenosis requiring valve replacement and the other with aortic regurgitation requiring close monitoring.
1. Case 1
62-year-old woman with medical history signiﬁcant for
aortic stenosis and chronic atrial ﬁbrillation presented to
the emergency department with fatigue and progressively
worsening shortness of breath with minimal exertion. She
was asymptomatic at rest and denied chest pain, orthopnea,
paroxysmal nocturnal dyspnea, leg swelling, presyncope, or
syncope. She was incidentally found to have a systolic
murmur during her pregnancy 20 years prior to this
presentation. Notably, she had been oﬀered aortic valve
replacement in the past but declined.
Vital signs were normal with blood pressure of
110/60 mmHg, pulse rate of 79/min, temperature of
97.2°F, and respiratory rate of 16 breaths/min with normal
oxygen saturation of 100% on ambient air. Physical exami-
nation was signiﬁcant for irregularly irregular heart rhythm,
and ejection systolic murmur was loudest in the aortic area
with radiation to the carotids. Her lungs were clear to
auscultation, and no pedal edema was noted. Electrocardio-
gram revealed atrial ﬁbrillation with voltage criteria for left
ventricular hypertrophy. Her most recent transthoracic
echocardiogram revealed a thickened calciﬁed aortic valve
with decreased excursion with 4.6 m/s velocity suggesting
a peak of 86 mmHg and mean of 36 mmHg suggestive
of severe aortic stenosis. No other signiﬁcant valvular
abnormalities noted. Cardiac catheterization revealed widely
patent coronary arteries.
Based on the presence of worsening symptoms and the
risk of sudden cardiac death, the decision was made to
proceed with surgical aortic valve replacement. Given her
history of chronic atrial ﬁbrillation, she was also planned
for left atrial appendage exclusion and Cox Maze IV
procedure simultaneously with the aortic valve replacement.
Intraoperative transesophageal echocardiogram revealed
quadricuspid aortic valves conﬁrmed during surgical explo-
ration (Figure 1). The native stenotic quadricuspid aortic
valve leaﬂets were excised, and a 21 mm Saint Jude Medical
Trifecta valve was implanted. The left atrial appendage was
excised, and CoxMaze IV procedure was performed. Postop-
eratively, she remained in junctional rhythm and underwent
uneventful placement of the dual chamber pacemaker on
postoperative day 3. She recovered without further complica-
tions and was discharged on the eight postoperative day.
2. Case 2
53-year-old female with past medical history of aortic regur-
gitation and hypertension presented to the cardiology oﬃce
for routine follow-up. She denied chest pain, shortness of
breath, orthopnea, dyspnea, or leg swelling. Physical exami-
nation revealed normal vital signs. Cardiac auscultation
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revealed diastolic murmur loudest at the 3rd left intercostal
space. The remainder of physical examination was unre-
markable. Transthoracic echocardiogram (TTE) 3 months
earlier revealed a trileaﬂet aortic valve with moderate aortic
insuﬃciency. TTE also noted a poorly deﬁned subaortic
membrane which prompted further assessment of valve
anatomy by transesophageal echocardiogram (TEE) which
conﬁrmed the presence of quadricuspid aortic valve with
severe aortic regurgitation from incomplete coaptation of
the valve leaﬂets. Given that she was asymptomatic, we
planned to continue surveillance by clinical and echocardio-
graphic monitoring.
3. Discussion
The normal aortic valve is trileaﬂet and with the pulmonary
valve represents the two semilunar heart valves. The leaﬂets,
namely, right coronary, left coronary, and noncoronary
cusps, are named based on their relationship to the coronary
arteries [1]. Anatomical variations of the aortic valve have
been documented notably, the unicuspid, bicuspid, and
quadricuspid valves. Of these variants, the bicuspid valve is
the commonest followed by unicuspid valve [2]. Quadricus-
pid aortic valve (QAV) is a rare congenital anomaly with
documented incidence of 0.008% by autopsy, 0.043% by
transthoracic echocardiogram, and 1% intraoperatively dur-
ing aortic valve surgery [3, 4]. While both of our patients
were female, it has been shown to have a slightly higher male
preponderance [5] with mean age of presentation between 46
and 50 years. The embryology of QAV remains poorly
understood, but it is believed to result from aberrant division
of one of the three mesenchymal ridges that normally gives
rise to three aortic valve cushions [6, 7]. Acquired heart
diseases such as infective endocarditis and rheumatic fever
may contribute to the development of a false QAV, but the
absence of corpus arantii (nodules of semilunar cusps) helps
to distinguish true congenital from an acquired QAV [8].
Hurwitz and Roberts described the seven (A–G; Figure 2)
most common anatomic variants of QAV based on the size
of the valve leaﬂets [9]. Type A has 4 equal cusps, type B
has 3 normal cusp and a small accessory cusp, and type C
has 2 large cusps and 2 small cusps. Types A and B represent
about 73% of all the cases of QAV [10]. Other classiﬁcation
systems exist based on the position of the accessory cusps as
described by Nakamura et al. [11] (Figure 3). In type I, the
supernumerary cusp lies between the left and right coronary
cusps. In type II, it lies between the right and noncoronary
cusps. In type III, it lies between the left and noncoronary
cusps, and in type IV, the supernumerary cusp cannot be iden-
tiﬁed as there are 2 equal sized smaller cusps. It is important to
note that the position of the accessory cusp has no eﬀect on the
severity of the valvular insuﬃciency [4, 12]. Based on these
classiﬁcations, our ﬁrst patient hadHurwitz type C andNaka-
mura type IV while the second patient likely has Hurwitz type
A and Nakamura type I quadricuspid aortic valve.
Quadricuspid aortic valve (QAV) usually presents as an
isolated congenital anomaly, but other associated cardiac
anomalies have been reported in about 18-32% of cases
including aortic root dilatation [13], tetralogy of Fallot [14],
patent ductus arteriosus [15], atrial and ventricular septal
defects [16, 17], and anomalous origin of the coronary
arteries [12].
Clinical presentation varies being mostly asymptomatic
in the young, recall that both patients were asymptomatic
until adulthood. The symptomatic patients will present with
palpitations, dyspnea, fatigue, chest pain, and feature of
congestive heart failure. Cases of ischemic stroke as an initial
presentation has been reported [18]. Patients with QAV
mostly present with aortic insuﬃciency and less commonly
aortic stenosis [5]. More than half will present in adulthood
with features of aortic insuﬃciency and more than 50% will
require aortic valvular replacement in the sixth and seventh
decade of life due to worsening aortic regurgitation [2, 19].
Infective endocarditis occurs in 1.4% of these patients [8]
depending on the Hurwitz classiﬁcation and its eﬀect on
dynamics of blood ﬂow across the valve as mechanical stress
on the abnormal valves [20] is thought to play a key role.
The routine use of echocardiography in suspected cases
of valvular heart disease has allowed for early and accurate
diagnosis of QAV. Although transthoracic echocardiography
is often used in clinical settings, transesophageal echocardi-
ography provides a more accurate assessment of valvular
anatomy [8]. Magnetic resonance imaging and computerized
tomography can also aid diagnosis, although not generally
used solely for this purpose [18, 21]. In the absence of
symptoms as described above, patients with QAV should be
followed up closely. For symptomatic patients, treatment
options range from valve repair to valve replacement. Repair
may be feasible in some patients, but most will require valve
replacement. Valve replacement, which could be surgical as
in the ﬁrst case described or transcatheter, is preferred in
patients with severe aortic valvular dysfunction. Tricuspidali-
zation is a preferred repair option in patients with Hurwitz
types A, B, and C QAV [4].
4. Conclusion
Quadricuspid aortic valve is a rare congenital cardiac defect
usually diagnosed incidentally. While most patients develop
aortic regurgitation later in life, some as reported in the ﬁrst
case develop aortic stenosis while others remain asymptom-
atic. Although there are no guideline-based approach to
management, it is prudent to regularly follow up these
patients for early signs of aortic valve dysfunction.
Figure 1: Intraoperative image showing quadricuspid aortic valve:
Hurwitz type C/Nakamura type IV.
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